TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $322,000 | -15.7% | 19,135 | -8.5% | 0.01% | -33.3% |
| Q1 2021 | $382,000 | +3.2% | 20,902 | +2.9% | 0.01% | 0.0% |
| Q4 2020 | $370,000 | -2.4% | 20,311 | -4.3% | 0.01% | -18.2% |
| Q3 2020 | $379,000 | -2.1% | 21,228 | -1.7% | 0.01% | -8.3% |
| Q2 2020 | $387,000 | +5.4% | 21,599 | -10.8% | 0.01% | -20.0% |
| Q1 2020 | $367,000 | -20.9% | 24,207 | +2.9% | 0.02% | 0.0% |
| Q4 2019 | $464,000 | +118.9% | 23,519 | +96.4% | 0.02% | +50.0% |
| Q2 2019 | $212,000 | -24.3% | 11,974 | -13.0% | 0.01% | -28.6% |
| Q1 2019 | $280,000 | – | 13,763 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |